Name

SERAG-WIESSNER

Legal name

SERAG-WIESSNER GmbH & Co. KG

Website

https://serag-wiessner.de

Company type

Private

Founded year

1860

Operating status

Operating

Headcount range

101–250 employees

Short description

SERAG-WIESSNER is a family-owned German medical device manufacturer founded in 1866, producing surgical sutures, textile implants, needles, and wound management products for hospitals, surgical centers, and specialty practices across the DACH region and Czech Republic.

Ownership category

akta.pro rank

Product category

Surgical Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

akta.pro secondary industries

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG), Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics) (IMAOADAD)

Keywords

• Surgical suture materials
• Textile mesh implants
• Wound care products
• Surgical needles
• Sterile medical devices

Headquarters

HQ city

Naila

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of surgical suture materials, textile implants, surgical needles, and wound management products to hospitals, surgical centers, and medical practices. Products sold through direct sales and e-commerce channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

SERAG-WIESSNER manufactures and sells surgical suture materials (both absorbable and non-absorbable), stainless steel surgical needles, textile mesh implants for hernia, breast and pelvic floor surgery, sterile infusion and irrigation solutions, and wound management products (irrigation solutions, gels, sprays, skincare creams). All products are produced in its own ISO 13485-certified cleanroom facilities in Naila, Germany, and sold under proprietary SERA, SERAMESH, SERAPRO, LAVANID and LAVANOX-Serag brands to healthcare providers.

Product overview

SERAG-WIESSNER is a German family-owned medical device manufacturer with over 160 years of history, producing surgical suture materials, surgical needles, textile implants, solutions, and wound management products. The company offers two main categories of suture materials: absorbable sutures (SERAFIT®, SERAFIT® PROTECT, SERAPID®, SERAFAST®, SERASYNTH®, SERASYNTH® LOC) made from polymers like polyglycolic acid and polydioxanone; and non-absorbable sutures (SERALON®, SUPRAMID, NYLON, SULENE®, TERYLENE, SERACOR®, SERAPREN®, SERALENE®, SERAMON®, SERANOX®) made from polymers, stainless steel, and other materials. Textile implants include hernia meshes (SERAMESH® PA, SERAMESH® PA DRUM), breast reconstruction meshes (SERASYNTH® MESH BR, SERAGYN® BR PA), and pelvic floor repair products (SERASIS®, SERATEX®, SERATEX® SlimSling®, SERATOM® PA). The company also produces pharmaceutical solutions for infusion and irrigation, wound management products (LAVANID®, LAVANOX-Serag®, LAVA-Repair®), and digital services including an eIFU portal and video portal. Supporting these products are surgical instruments (SERAPRO® instruments) and online e-commerce capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• SERA: Product brand prefix for suture materials (e.g., SERAFIT, SERAPID, SERASYNTH, SERALON, SERACOR, SERAPREN, SERALENE, SERAMON, SERANOX)
• SERAMESH
• LAVANID
• LAVANOX-Serag
• LAVA-Repair
• SERAPRO
• SUPRAMID

Products and services

• Absorbable suture materials SERA-branded absorbable sutures based on polyglycolic acid, polyglycolic acid-caprolactone and polydioxanone, available as multifilament/braided and monofilament configurations for short-, medium- and long-term absorption. Intended for use by surgical departments in hospitals and surgical centers for wound closure across general and specialized procedures.
• Non-absorbable suture materials SERA-branded non-absorbable sutures made of polyamide, polyester, polypropylene, polyvinylidene fluoride, PTFE and stainless steel (including titanium-coated steel), supplied as multifilament, monofilament or coated variants in multiple colors and USP sizes. Intended for long-term wound closure and specialist procedures such as cardiac surgery and chordae repair in hospitals and surgical centers.
• Surgical needles Stainless steel surgical needles in eye-needle and other geometries, including an interactive 3D needle showroom for visualization. Intended for use by surgeons in operating rooms across general and specialist surgical procedures.
• SERAMESH PA textile implants SERAMESH PA polypropylene or polypropylene/polyglycolic acid-caprolactone mesh implants, available as non-absorbable or partially absorbable variants. Intended for use by surgical departments in hernia repair and tissue support procedures.
• SERAMESH PA DRUM textile implant Adaptable SERAMESH PA DRUM mesh implants specifically designed for hiatus hernia repair. Sold to surgical centers and hospitals performing upper GI and hernia surgery.
• SERASYNTH MESH textile implant SERASYNTH MESH polydioxanone absorbable mesh implants for tissue support, fully absorbed after approximately 30 weeks. Intended for hospitals and surgical centers needing temporary tissue support.
• SERASYNTH MESH BR Pocket SERASYNTH MESH BR Pocket is a 100% polydioxanone absorbable surgical mesh pocket for pre-pectoral breast reconstruction with an implant, absorbing in approximately 30 weeks with low wrinkle formation. Intended for breast surgeons and surgical centers performing implant-based breast reconstruction.
• SERAGYN BR PA and SERASYNTH MESH BR breast reconstruction implants SERAGYN BR PA (partially absorbable) and SERASYNTH MESH BR (fully absorbable) mesh implants for breast reconstruction following mastectomy, providing soft tissue reinforcement. Intended for breast and plastic surgeons in hospitals performing post-mastectomy reconstruction.
• SERASIS and SERASIS PA female incontinence implants SERASIS and SERASIS PA polypropylene or polypropylene/polyglycolic acid-caprolactone partially absorbable mesh implants for female stress incontinence treatment. Intended for gynecology and urology practices performing anti-incontinence surgery.
• SERATEX and SERATEX PA gynecological laparoscopy implants SERATEX and SERATEX PA polypropylene or polypropylene/polyglycolic acid-caprolactone non-absorbable or partially absorbable mesh implants for gynecological laparoscopy. Intended for gynecology surgical departments and urogynecologists.
• SERATEX DVF PA MR pelvic floor prolapse implant SERATEX DVF PA MR mesh implant indicated for the treatment of patients with pelvic floor prolapse. Sold to gynecology and urogynecology surgical centers for pelvic floor repair procedures.
• SERATEX SlimSling pelvic floor implant SERATEX SlimSling combination of a textile ligament implant with an atraumatic needle for female pelvic floor reconstruction. Intended for gynecology and urogynecology surgeons performing pelvic floor repair.
• SERATOM PA pelvic floor reconstruction implant SERATOM PA polypropylene/polyglycolic acid-caprolactone partially absorbable mesh implant for female pelvic floor reconstruction and prolapse treatment. Intended for gynecology and urogynecology surgical centers.
• SERAPRO and SERASIS surgical instruments SERAPRO and SERASIS stainless steel surgical instruments including suturing instruments designed for use with SERAG-WIESSNER textile implants. Intended for surgeons performing implant procedures in gynecology and urology.
• SERAPRO ARSD-Ney and ARSD-Ney TTT single-incision suturing instruments SERAPRO ARSD-Ney and ARSD-Ney TTT novel high-precision suturing instruments designed for safe single-incision applications in sling and pelvic floor procedures. Intended for surgeons performing single-incision anti-incontinence or pelvic floor surgery.
• SERAPRO VR retropubic suturing instrument SERAPRO VR dismantlable and reprocessable accessory instrument made from surgical steel for implantation of textile implants, specifically designed for retropubic passage. Intended for use with SERAG-WIESSNER sling and pelvic floor implants in hospitals and surgical centers.
• ENDO-NAHT MSD Ney transurethral suturing instrument ENDO-NAHT MSD Ney transurethral suturing instrument designed for direct access during urological and pelvic floor suturing procedures. Sold to urology and gynecology surgical centers performing transurethral suturing.
• Standard infusion solutions Standard electrolyte, carrier and carbohydrate solutions for infusion therapy. Manufactured under cleanroom conditions for use in hospitals and clinics as part of infusion therapy regimens.
• Sterile irrigation solutions Sterile cleansing and eye irrigation solutions for surgical use. Manufactured for hospital surgical departments and operating rooms requiring sterile intra-operative and ocular irrigation.
• Individual custom solution formulations Custom solution formulations developed for individual customer requirements and specific indications, including small-batch sterile liquids. Intended for hospitals and specialized customers needing indication-specific sterile liquid pharmaceutical forms.
• LAVANID wound irrigation solutions LAVANID wound irrigation solutions preserved with polyhexanide for modern moist wound treatment. Intended for wound care centers, hospital outpatient wound services and chronic wound patients.
• LAVANID wound gels and wound gel V+ LAVANID Wound Gel and Wound Gel V+ hydrogels with preservative, available in varying degrees of viscosity for moist wound treatment. Intended for wound care centers, hospitals and outpatient wound services.
• LAVANOX-Serag wound irrigation solution and wound spray LAVANOX-Serag wound irrigation solution and wound spray based on water with 0.08% sodium hypochlorite for wound irrigation and cleansing. Intended for wound care centers, hospitals and outpatient services treating chronic or infected wounds.
• LAVANOX-Serag wound spray gel (hydrogel) LAVANOX-Serag hydrogel wound spray in an innovative dosage form for easy application, preserved with sodium hypochlorite/hypochlorous acid. A 50 ml tube with applicator format was launched in 2025. Intended for wound care professionals and outpatient use.
• LAVA-Repair skincare cream LAVA-Repair cosmetic skincare cream containing PHMB (polyhexanide) and urea for intensive care of irritated, dry and heavily stressed skin. Intended as a supportive skincare product for wound care patients and healthcare users.

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Ethicon (Johnson & Johnson MedTech): Global market leader in surgical sutures, meshes, and wound closure products within J&J MedTech; directly competes with SERAG-WIESSNER across absorbable sutures, hernia mesh, and specialty implant categories, but at substantially larger scale and broader portfolio breadth.
• Becton, Dickinson and Company (BD): Global medical technology company with a large surgical and infection prevention portfolio including sutures, mesh, and sterilization products; competes with SERAG-WIESSNER as a broad incumbent in hospital surgical supplies and wound closure.

Emerging players

• Coloplast: Danish medtech with wound care and surgical portfolios including ostomy, continence, and wound dressings; partial overlap with SERAG-WIESSNER's incontinence mesh (SERASIS) and wound management products in European hospitals and specialty clinics.
• Mölnlycke Health Care: Global wound care specialist overlapping with SERAG-WIESSNER's LAVANID and LAVANOX wound irrigation and gel portfolio; Mölnlycke focuses on advanced wound care dressings and offers an adjacent rather than directly competing channel in the same hospital accounts.
• Smith & Nephew: Global medical device company with wound management, sports medicine, and orthopedic franchises; competes with SERAG-WIESSNER in advanced wound care and adjacent surgical categories though with much broader scale and product breadth.

Direct peers

• B. Braun (Aesculap division): German-headquartered medical device manufacturer with a global surgical sutures and instruments business (Aesculap) that directly competes with SERAG-WIESSNER in absorbable/non-absorbable sutures, surgical needles, and suture-based procedure kits sold to hospitals and surgical centers.
• Peters Surgical: France-based independent manufacturer of surgical sutures, surgical gloves, and specialty surgical devices serving hospitals and surgical centers across Europe; the closest like-for-like mid-sized European competitor to SERAG-WIESSNER in absorbable sutures and surgical consumables.
• DemeTech: US- and Latin America-based manufacturer of surgical sutures (absorbable and non-absorbable) and mesh products, comparable to SERAG-WIESSNER in product mix and mid-sized independent positioning across surgical wound closure.
• Assut Europe: European manufacturer of surgical sutures, meshes, and wound care products; competes with SERAG-WIESSNER in absorbable sutures, hernia meshes, and specialty surgical implants sold to European hospitals.

Others

• Medtronic (Surgical Innovations / Covidien heritage): Large diversified medtech with a significant surgical sutures, mesh, and wound management portfolio inherited from Covidien; competes with SERAG-WIESSNER across hernia meshes, sutures, and specialty surgical products, offering hospitals a broad-line procurement option.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/serag-wiessner

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SERAG-WIESSNER